Science Explorer Back to mapMap

Most cited papers from AIM at Melanoma Foundation

What are the most cited papers from AIM at Melanoma Foundation?

The most cited paper from AIM at Melanoma Foundation is "Guidelines of care for the management of primary cutaneous melanoma" (Susan M. Swetter, Hensin Tsao, Christopher Keram Bichakjian et al., 2018), with 735 citations. Next come "Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134" (474) and "Systemic Therapy for Melanoma: ASCO Guideline" (270).

Showing 9 of 9 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines of care for the management of primary cutaneous melanoma Susan M. Swetter, Hensin Tsao, Christopher Keram Bichakjian et al. · Journal of the American Academy of Dermatology Nov 2018 735
2 Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 Michael B. Atkins et al. · Journal of Clinical Oncology Open access 27 Sep 2022 474
3 Systemic Therapy for Melanoma: ASCO Guideline Rahul Seth et al. · Journal of Clinical Oncology 31 Mar 2020 270
4 Systemic Therapy for Melanoma: ASCO Guideline Update Rahul Seth et al. · Journal of Clinical Oncology Open access 14 Aug 2023 224
5 Melanoma, Version 4.2014 Daniel G. Coit et al. · Journal of the National Comprehensive Cancer Network Open access May 2014 78
6 Progression of cutaneous melanoma: implications for treatment Stanley P. L. Leong, Martín C. Mihm, Gëorge F. Murphy et al. · Clinical & Experimental Metastasis Open access 14 Aug 2012 39
7 Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma Guilherme Rabinowits, Michael Robert Migden, Todd E. Schlesinger et al. · JID Innovations Open access 25 Aug 2021 35
8 HSR23-110: Immune Checkpoint Inhibitor (ICI) Treatment After Progression on Anti–PD-1 Therapy in Advanced Melanoma: A Systematic Review of the Literature Daniel J. Olson, Brian Gastman, Alicia Rowell et al. · Journal of the National Comprehensive Cancer Network 31 Mar 2023 1
9 Multidisciplinary Expert-Driven Consensus on the Evolving Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma Michael Robert Migden, Todd E. Schlesinger, Chrysalyne Delling Schmults et al. · SKIN The Journal of Cutaneous Medicine Open access 9 Nov 2019 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.